Incidence, Timing, and Correlates of Stent Thrombosis With the Polymeric Paclitaxel Drug-Eluting Stent. A TAXUS II, IV, V, and VI Meta-Analysis of 3,445 Patients Followed for Up to 3 Years

Journal of the American College of Cardiology

Volumn 49, Issue 10, 2007, Pages 1043-1051

  Ellis, Stephen G ^a   Colombo, Antonio ^b   Grube, Eberhard ^c   Popma, Jeffrey ^d   Koglin, Joerg ^e   Dawkins, Keith D ^f   Stone, Gregg W ^g  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EMO GVM Centro Cuore   (Italy)

^c Heart Center Siegburg   (Germany)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BOSTON SCIENTIFIC CORPORATION   (United States)

^f UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^g NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SMOKING; THROMBOSIS;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG ADMINISTRATION ROUTES; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PROBABILITY; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; STENTS; SURVIVAL ANALYSIS; TAXUS; THROMBOSIS; TIME FACTORS;

EID: 33847657146     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.01.015     Document Type: Article

References (23)

1. Cutlip D.E., Baim D.S., Ho K.L., et al. Stent thrombosis in the modern era-a pooled analysis of multicenter coronary stent clinical trials. Circulation 103 (2005) 1967-1971
2. Kernis S.J., Choen D., Reid K., et al. Clinical outcomes associated with use of DES compared with bare-metal stents for primary percutaneous intervention. Am J Cardiol 96 (2005) 7-47
3. Fuji K., Carlier S.G., Mintz G.S., et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation. J Am Coll Cardiol 45 (2005) 995-998
4. Moussa I., DiMario C., Reimers B., et al. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 29 (1997) 6-12
5. Schomig A., Neumann F.-J., Kastrati A., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334 (1996) 1084-1089
6. Leon M.B., Baim D.S., Popma J.J., et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 23 (1998) 1665-1671
7. Wenaweser P., Dörffler-Melly J., Imboden K., et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 45 (2005) 1748-1752
8. Kaluza G.L., Joseph J., Lee J.R., Raizner M.E., and Raizner A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 (2000) 1288-1294
9. Farb A., Heller P.F., Shroff S., et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104 (2001) 473-479
10. Rogers C., Parikh S., Seifert P., and Edelman E.R. Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. Circulation 94 (1996) 2909-2914
11. Moreno R., Fernández C., Hernández R., et al. Drug-eluting stent thrombosis-results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
12. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of DES. JAMA 293 (2005) 2126-2130
13. Ong A.T., McFadden E.P., Regar E., deJaegere P.P., vanDomburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with DES. J Am Coll Cardiol 45 (2005) 2088-2092
14. Colombo A., Drzewiecki J., Banning A., et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
15. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-321
16. Ellis S.G., O'Shaughnessey C.D., Powers E., et al. Twelve-month clinical outcomes of paclitaxel-eluting stents in complex lesions (Taxus V): focus on late clinical benefits and stent thrombosis risk (abstr). Circulation 112 (2005) 3062
17. Dawkins K.D., Grube E., Guagliumi G., et al., Taxus VI Investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
18. Moreno R., Fernandez C., Hernandez R., et al. Drug-eluting stent thrombosis. J Am Coll Cardiol 45 (2005) 954-959
19. Stone G.W., Ellis S.G., O'Shaughnessy C., et al. Reduction of late loss and restenosis in patients with small vessels treated with the slow rate-release, polymer-based paclitaxel-eluting stent: results from Taxus-IV (abstr). J Am Coll Cardiol 43 (2004) 87A
20. Stone GW, Ellis GW, O'Shaughnessy C, et al. Reduction in late loss and restenosis in patients with small vessels treated with the slow rate-release, polymer-based paclitaxel-eluting stent: results from TAXUS-IV. Paper presented at: American College of Cardiology Annual Scientific Session; March 11-14, 2004; New Orleans, LA.
21. Spertus J.A., Kettelkamp R., Vance C., et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 (2006) 2803-2809
22. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2005) 498-502
23. Leone MB, Stone GW, Kirtane A. Independent physician-led patient-level analysis of the CYPHER randomized trials. Paper presented at: Transcatheter Cardiovascular Therapeutics Conference; October 23-27, 2006; Washington, DC.